SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neurocrine Analysis Sets 6-Point EQ-VAS Benchmark for Tardive Dyskinesia

An analysis sets a 6-point EQ-VAS benchmark for meaningful health improvement in tardive dyskinesia.

NBIX

Related stories